Loading...
 
Translate Register Log In Login with facebookLogin and Register

Omega-3 in infancy reduces Obesity following antibiotic (confirmed in rats, suspected in humans) – Feb 2016

Omega-3 fatty acids prevent early-life antibiotic exposure-induced gut microbiota dysbiosis and later-life obesity.

Int J Obes (Lond). 2016 Feb 15. doi: 10.1038/ijo.2016.27. [Epub ahead of print]
Kaliannan K1, Wang B1, Li XY1, Bhan AK2, Kang JX1.
1Laboratory for Lipid Medicine and Technology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
2Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Early-life antibiotic exposure can disrupt the founding intestinal microbial community and lead to obesity later in life. Recent studies show that omega-3 fatty acids can reduce body weight gain and chronic inflammation through modulation of the gut microbiota.
We hypothesize that increased tissue levels of omega-3 fatty acids may prevent antibiotic-induced alteration of gut microbiota and obesity later in life.
Here, we utilize the fat-1 transgenic mouse model, which can endogenously produce omega-3 fatty acids and thereby eliminates confounding factors of diet, to show that elevated tissue levels of omega-3 fatty acids significantly reduce body weight gain and the severity of insulin resistance, fatty liver and dyslipidemia resulting from early-life exposure to azithromycin.
These effects were associated with a reversal of antibiotic-induced dysbiosis of gut microbiota in fat-1 mice.

These results demonstrate the beneficial effects of omega-3 fatty acids on antibiotic-induced gut dysbiosis and obesity, and suggest the potential utility of omega-3 supplementation as a safe and effective means for the prevention of obesity in children who are exposed to antibiotics.

PMID: 26876435
Publisher rents PDF for $5


See also VitaminDWiki

See any problem with this page? Report it (FINALLY WORKS)